Key Points
It missed the consensus analyst net income estimate in its final quarter of 2025.
It did beat on revenue, however.
- 10 stocks we like better than Pediatrix Medical Group ›
Pediatrix Medical Group (NYSE: MD) wasn't one of the healthier stocks on the U.S. market on Thursday. The healthcare services provider's shares fell by more than 12% over the course of the day, due mostly to the earnings report it published early that morning.
Double dips
In its fourth quarter, Pediatrix's revenue came in at nearly $493.8 million, down almost 2% year over year. Net income not in accordance with generally accepted accounting principles (GAAP) also dipped slightly, falling to $42.5 million ($0.50 per share) from the year-ago profit of $43.5 million.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »
Image source: Getty Images.
That meant a mixed quarter for the company, as analysts collectively modeled lower revenue ($486.2 million) but higher profitability. Their consensus for non-GAAP (adjusted) net income was $0.54 per share.
The company's bottom line was negatively affected by notably higher bonus payouts to its practitioners, which, in turn, stem from a tightening labor market for such professionals.
Insubstantial gains?
In its earnings release, Pediatrix proffered very selected guidance, stating that it expects adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of $280 million to $300 million for full-year 2026. The previous year's figure was $275.6 million.
That issue with costs is certainly a concern, though over the years, Pediatrix has managed to deliver growth and decent bottom-line profits in adverse circumstances. At the same time, given the tepid growth figures analysts anticipate for the coming year, I don't feel it's a compelling buy, even at the beaten-down price following earnings.
Should you buy stock in Pediatrix Medical Group right now?
Before you buy stock in Pediatrix Medical Group, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Pediatrix Medical Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $420,595!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,152,356!*
Now, it’s worth noting Stock Advisor’s total average return is 899% — a market-crushing outperformance compared to 194% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of February 19, 2026.
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
